Modular Medical Inc. Faces Potential Delisting from Nasdaq Over Sub-$1 Stock Price

Reuters
03 Jul
Modular Medical Inc. Faces Potential Delisting from Nasdaq Over Sub-$1 Stock Price

Modular Medical Inc. announced on June 30, 2025, that it received a notification from the Nasdaq Stock Market regarding its failure to meet the minimum bid price requirement of $1 per share, as per Nasdaq Listing Rule 5550(a)(2). The company's stock has been trading below this threshold for 30 consecutive business days, ending on June 27, 2025. As a result, Modular Medical has been given a 180-day period, until December 29, 2025, to regain compliance by ensuring its stock price is at least $1 per share for ten consecutive business days. If the company fails to meet this requirement, it may seek an additional 180-day extension by meeting other listing standards and potentially implementing a reverse stock split. The company is currently exploring its options to address the issue, while its stock remains listed on the Nasdaq Capital Market.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Modular Medical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-061072), on July 02, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10